http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61180751-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f8cfa5aee4410611b5c562275c9f8e3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00 |
| filingDate | 1985-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eadf5e0959df64963927db2a062a71d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_638dd9ca1a93e62430ffe1e4275d835e |
| publicationDate | 1986-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S61180751-A |
| titleOfInvention | Beta-(acetylamino)acrylic ester |
| abstract | NEW MATERIAL:A β-(acetylamino)acrylic ester shown by the formula I (R is alkyl, or aryl). n USE: A compound to be expected as a raw material for drugs, being converted to a β-alanine derivative by reduction. n PREPARATION: An alkali formylacetic ester shown by the formula II (M is Na, K, or Li) is reacted with a mineral acid salt of acetamide shown by the formula III (X is halogen, HSO 4 , or NO 3 ) in the presence of a solvent, to give a compound shown by the formula I. The reaction is carried out at 50W150°C preferably for about 1W20hr. A solvent (e.g., DMF, DMSO, THF, etc.) inert to the alkali formylacetic ester and the mineral acid salt of acetamide is prefer able as the solvent. n COPYRIGHT: (C)1986,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5304820-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4004523-A1 |
| priorityDate | 1985-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.